{
    "symbol": "CMPS",
    "quarter": 2,
    "year": 2022,
    "date": "2022-08-04 13:56:02",
    "content": " As you heard from guy, we are pleased with the progress of our FDA interactions and we look forward to sharing our Phase III program in our upcoming Investor Day on October 12th, which will also feature our TRD commercial strategy, our advanced suite of digital tools, additional information on our PTSD and anorexia programs and perspectives from KOLs. Thank you very much. Thank you very much. Thank you very much. Thank you very much. Thank you very much. Thank you very much."
}